Despite sometimes lingering and understandable frustration with the time, expense and challenge of clinical trial patient recruitment, it is worth pausing to take stock of the evolution and progress that has been achieved — and recognize how far the industry has come collectively.
Part of the challenge is that with the evolution of protocol design, precision-medicine science and rare-disease targeting, sponsors attempt to recruit smaller groups of people from smaller pools of potential participants, increasing the degree of difficulty. But while patient recruitment remains difficult, the industry’s knowledge, sensitivity and agility have improved dramatically — and we see a progression from a vision of participant homogeneity, passivity and hesitance to one of participant heterogeneity, agency and interest. This playbook explores:
Download the playbook to learn more about the drivers impacting recent shifts in clinical trial recruitment strategy — and how today's sponsors can leverage both historical and current insights to maximize value when collaborating with recruitment partners.
Thank you for your interest in the playbook! Click below to get your copy.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again